Your browser doesn't support javascript.
loading
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
Advani, Anjali S; Moseley, Anna; O'Dwyer, Kristen M; Wood, Brent L; Fang, Min; Wieduwilt, Matthew J; Aldoss, Ibrahim; Park, Jae H; Klisovic, Rebecca B; Baer, Maria R; Stock, Wendy; Bhave, Rupali R; Othus, Megan; Harvey, Richard C; Willman, Cheryl L; Litzow, Mark R; Stone, Richard M; Sharon, Elad; Erba, Harry P.
Affiliation
  • Advani AS; Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH.
  • Moseley A; SWOG Statistics and Data Management Center, Seattle, WA.
  • O'Dwyer KM; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Wood BL; Department of Medicine, Hematology/Oncology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, MN.
  • Fang M; Department of Laboratory Medicine, University of Washington, Seattle, WA.
  • Wieduwilt MJ; Current address: Department of Hematopathology, Children's Hospital of Los Angeles, CA.
  • Aldoss I; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Park JH; Division of Hematology/Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA.
  • Klisovic RB; Current address: Department of Medicine, University of Oklahoma, Oklahoma City, OK.
  • Baer MR; Department of Hematology & Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA.
  • Stock W; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY.
  • Bhave RR; Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA.
  • Othus M; Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD.
  • Harvey RC; Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL.
  • Willman CL; Division of Medical Oncology and Hematology, Wake Forest School of Medicine, Winston Salem, NC.
  • Litzow MR; SWOG Statistics and Data Management Center, Seattle, WA.
  • Stone RM; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Sharon E; Department of Pathology, University of New Mexico, Albuquerque, NM.
  • Erba HP; Department of Pathology, University of New Mexico, Albuquerque, NM.
J Clin Oncol ; 40(14): 1574-1582, 2022 05 10.
Article in En | MEDLINE | ID: mdl-35157496
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Antibodies, Bispecific / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies Limits: Aged / Humans Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Antibodies, Bispecific / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Diagnostic_studies Limits: Aged / Humans Language: En Journal: J Clin Oncol Year: 2022 Document type: Article Country of publication: Estados Unidos